Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

Дата публикации: 30-09-2026 17:48:56

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?	0	8.36	30-09-2026
2	Scientists Untangle the Biology of an ‘Undruggable’ Cancer Gene	0	11.1	02-10-2026
3	Study identifies potential RAS inhibitor-immunotherapy strategy for pancreatic cancer	0	7.48	23-09-2026
4	Everyday DNA damage reveals a hidden weakness in some cancers	0	9.5	28-09-2026
5	ABD, pankreas kanserinde 'çığır açıcı bir tedaviyi' onayladı	0	7.7	27-08-2026
6	Catching pancreatic cancer early: A Northwestern Medicine doctor's mission	0	7.12	15-09-2026
7	Science & Medicine: Studying the 'form and function' of prostate cancer's main driver leads to a breakthrough	0	5.98	20-09-2026
8	From professor to patient: One man's journey on the frontier of lung cancer treatment	0	7.28	27-09-2026
9	From professor to patient: One man's journey on the frontier of lung cancer treatment	0	7.28	27-09-2026
10	My friend was refused cancer treatment with no explanation. A nurse then told him the sickening reason why... This cannot be true? DR SCURR reveals what's really going on	0	5.62	21-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.97. Источник: rss.nytimes.com.